Discovery Americas

About The Fund

Discovery Americas is a private equity firm based in Mexico City, Mexico, specializing in medium-sized company investments within the Mexican market since its inception in 2003. They seek to partner with Mexico's leading companies to foster growth and build substantial value. With a demonstrated 20-year track record, Discovery Americas has successfully established market-leading franchises through strong partnerships with exceptional teams. They possess notable experience in finance, strategy, capital markets, and mergers and acquisitions. Their expansive network includes industry experts, mentors, and advisors across Mexico, the United States, and Latin America. Committed to collaboration and nurturing long-term connections, Discovery Americas emphasizes a partnership approach that yields mutually beneficial results. The firm operates with an impact-driven philosophy, aiming to generate positive change within their portfolio companies and the communities they engage in. The culture at Discovery Americas is meritocratic, prizing teamwork, integrity, and excellence. As pioneers of the Mexican private equity industry, they have raised five funds and deployed $493 million capital while executing over 40 transactions. Discovery Americas boasts a diversified and seasoned team dedicated to building lasting partnerships with exceptional management teams, thus driving growth in the middle market. Their portfolio highlights their focus on key sectors such as education, healthcare services, and financial services, in addition to transportation and logistics, showcasing investments in companies like Servimsa, AISG, and KidZania. Discovery Americas continues to support businesses like KidZania, which provides innovative children's edutainment, reflecting their investment in the education sector. Their website outlines their vision and achievements, including their expansive portfolio, which features businesses in various industries signifying their diverse investment interest ranging from bio-tech and FinTech to health-tech, life science, and oncology.